KristenM.MarksMD
Infectious Disease • New York, NYAssistant Professor, Medicine, Weill Cornell Medical College
Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St Ste J314
New York, NY 10021Phone+1 212-746-7200
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2002 - 2005- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1999
Certifications & Licensure
NY State Medical License 2001 - 2025
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection Start of enrollment: 2005 Mar 01
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance Start of enrollment: 2009 Mar 01
- HCV Seek, Test and Rapid Treatment for Young PWID Start of enrollment: 2018 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.Kristen M Marks, Minhee Kang, Triin Umbleja, Andrea Cox, Karen J Vigil
JAMA. 2025-01-28 - Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model.Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, Chunki Fong, Shashi N Kapadia
Plos One. 2024-01-01 - 5 citationsCOVID-19.Kristen M Marks, Roy M Gulick
Annals of Internal Medicine. 2023-10-01
Journal Articles
- Benefit of Early Versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis Among People with HIV in the START Randomized TrialFred Gordin, Kristen Marks, Hepatology
Press Mentions
Updated Hep B Vaccine More Effective for People with HIVDecember 13th, 2024- New Hepatitis B Vaccine Offers Advanced Protection to People Living with HIVDecember 12th, 2024
- IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons with HIVOctober 26th, 2022
- Join now to see all
Grant Support
- Thrombocytopenia &Hiv/Hcv: Risk Factors &TreatmentNational Institute Of Allergy And Infectious Diseases2005–2009
- Safety/Efficacy Of IV Anti-D For Treatment Of Thrombocytopenia In HCVNational Center For Research Resources2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
